Recent research has implied that GPR27 might play critical roles during cancer progression, particularly in hepatocellular carcinoma (HCC) (Wang et al., 2022) and breast cancer (Milioli et al., 2017). Here, GPR27 is linked to hepatocellular carcinoma.